Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Fu's subcutaneous needling with rehabilitation to help heal distal radius fractures after closed reduction

Official title: Fu's Subcutaneous Needling-assisted Conservative Treatment for Distal Radius Fracture Healing: Protocol for a Randomized Controlled Trial

Run by Guangzhou University of Chinese Medicine · NCT07054463 · Data updated 2026-11-12

This trial will test whether adding Fu's subcutaneous needling to standard rehabilitation helps adults (18–85) heal distal radius fractures after closed reduction and splinting.

More Distal Radius Fractures trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment84 (estimated)
SponsorGuangzhou University of Chinese Medicine
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedApril 15, 2025
Main results expectedDecember 2026
Study endsMay 2027
Registry record updatedAugust 19, 2025
Trial IDNCT07054463 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–85 with a first acute distal radius fracture (≤2 weeks) treated with closed reduction and splinting who can provide informed consent and have not previously received FSN.

Probably not a fit

Patients with open, pathological, or nonacute (>2 weeks) fractures, those with significant bleeding or clotting disorders, or patients who require immediate surgical fixation are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial compares Fu's subcutaneous needling (FSN) plus standardized rehabilitation to a sham FSN procedure plus the same rehabilitation in adults with acute distal radius fractures treated non-surgically. Participants receive 12 sessions of FSN or sham therapy over 8 weeks and undergo periodic clinical and radiographic assessments, including radiographic union, pain, swelling, joint mobility, volar tilt, and radial height. Enrollment is limited to patients aged 18–85 within one week after closed reduction and splint immobilization, with follow-up visits scheduled at early time points (e.g., weeks 2 and 4) and later outcome assessments. The trial aims to see if FSN accelerates fracture union and leads to better functional and anatomical recovery compared with sham.

Why it matters

Potential benefit: If successful, FSN could speed radiographic healing and improve pain, mobility, and anatomical alignment after non-surgical treatment of distal radius fractures.

How similar studies have gone: There are limited small studies and case reports suggesting FSN and related needling techniques can improve musculoskeletal pain and function, but robust randomized evidence showing accelerated fracture union is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants meeting the diagnostic criteria for distal radius fractures as outlined in both the Evidence-Based Guidelines for Diagnosis and Treatment of Adult Distal Radius Fractures (2024) (10) and the clinical practice guidelines (CPG) jointly issued by the American Academy of Orthopaedic Surgeons (AAOS) and the American Society for Surgery of the Hand (ASSH) (11), while also satisfying the following conditions, will be eligible for enrollment:

1. Within 1 week post closed reduction and small splint immobilization treatment.
2. Aged between 18 and 85 years (inclusive).
3. Fracture caused by trauma.
4. Acute fracture (≤2 weeks) or first-time fracture.
5. No prior history of receiving Fu's subcutaneous needling therapy.
6. Signed informed consent form obtained.

Exclusion Criteria:

1. Pathological, open, or nonacute fractures (\>2 weeks since injury).
2. Patients with thrombocytopenia, bleeding tendency, or coagulation disorders (INR \>1.5 or platelet count \<50×10⁹/L).
3. Cognitive impairment or psychiatric disorders affecting treatment compliance and follow-up.
4. Local skin lesions, pregnancy, or lactation.
5. History of syncope during Fu's subcutaneous needling therapy or intolerance to the procedure.
6. Participation in other interventional clinical trials within the past 3 months.

Where it's running

  • Guangdong Provincial Hospital of Chinese Medicine
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Jian Sun — Guangzhou University of Chinese Medicine - Department of Acupuncture and Rehabilitation Clinical Medicine
  • Study coordinator: Cheng Chen
  • Email: 1667277586@qq.com
  • Phone: +8615007086691

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.